Bafna Pharmaceuticals Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Bafna Pharmaceuticals Limited
Symbol
BAFNAPH
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Additional Disclosure Date
29-Apr-2026
Additional Disclosure Designation
CFO
Additional Disclosure Name Of Signatory
SRIDHAR MELAGIRI
Additional Disclosure Place
CHENNAI
Advertisements As Per Regulation471
Yes
Affirmations
All loans (or other form of debt), guarantees, comfort letters (by whatever name called) or securities in connection with any loan(s) (or other form of debt) given directly or indirectly by the listed entity to promoter(s), promoter group, director(s) (including their relatives), key managerial personnel (including their relatives) or any entity controlled by them are in the economic interest of the company.
Aggregate Amount Advanced During Six Months Of Any Loan Or Any Other Form Of Debt To KM Ps Or Any Other Entity Controlled By Them
0
Aggregate Amount Advanced During Six Months Of Any Loan Or Any Other Form Of Debt To Promoter Group Or Any Other Entity Controlled By Them
0
Aggregate Amount Advanced During Six Months Of Any Loan Or Any Other Form Of Debt To Promoter Or Any Other Entity Controlled By Them
0
Aggregate Amount Of Issuance During Six Months Of Any Guarantee Or Comfort To KM Ps Or Any Other Entity Controlled By Them
0
Aggregate Amount Of Issuance During Six Months Of Any Guarantee Or Comfort To Promoter Group Or Any Other Entity Controlled By Them
0
Aggregate Amount Of Issuance During Six Months Of Any Guarantee Or Comfort To Promoter Or Any Other Entity Controlled By Them
0
Aggregate Value Of Security Provided During Six Months Of Security In Connection With Loan Or Any Other Debt Avail By KM Ps Or Any Other Entity Controlled By Them
0
Aggregate Value Of Security Provided During Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Group Or Any Other Entity Controlled By Them
0
Aggregate Value Of Security Provided During Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Or Any Other Entity Controlled By Them
0
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Yes
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Not Applicable
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Not Applicable
Balance Outstanding At The End Of Six Months Any Loan Or Any Other Form Of Debt To KM Ps Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Any Loan Or Any Other Form Of Debt To Promoter Group Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Any Loan Or Any Other Form Of Debt To Promoter Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Any Guarantee Or Comfort To KM Ps Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Any Guarantee Or Comfort To Promoter Group Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Any Guarantee Or Comfort To Promoter Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Security In Connection With Loan Or Any Other Debt Avail By KM Ps Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Group Or Any Other Entity Controlled By Them
0
Balance Outstanding At The End Of Six Months Of Security In Connection With Loan Or Any Other Debt Avail By Promoter Or Any Other Entity Controlled By Them
0
Board Composition
Yes
Code Of Conduct
Yes
Company Remarks
It is hereby declared that the Company has not, directly or indirectly, extended any loans or any other form of debt, or provided any guarantees, comfort letters (by whatever name called), or securities in connection with any loan or other form of debt, to its promoters, promoter group, directors (including their relatives), key managerial personnel (including their relatives), or any entity controlled by them, except for loans granted to key managerial personnel as part of their service conditions.
Compliance Certificate
Yes
Compliance Status
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Yes
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
29-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Company Secretary and Compliance Officer
Designation Of Person Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Annual Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Quartely Affirmations
Company Secretary and Compliance Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
www.bafnapharma.com
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
www.bafnapharma.com
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
www.bafnapharma.com
Disclosure Web Link Of Company At Which Credit Rating Or Revision In Credit Rating Obtained Is Placed
www.bafnapharma.com
Disclosure Web Link Of Company At Which Details Of Business Is Placed
www.bafnapharma.com
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
www.bafnapharma.com
Disclosure Web Link Of Company At Which Financial Results Is Placed
www.bafnapharma.com
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
www.bafnapharma.com
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
www.bafnapharma.com
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
www.bafnapharma.com
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
www.bafnapharma.com
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
www.bafnapharma.com
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
www.bafnapharma.com
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
www.bafnapharma.com
Disclosure Web Link Of Secretarial Compliance Report Is Placed
www.bafnapharma.com
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Not Applicable
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Not Applicable
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE878I01022
Market Capitalisation As Per Immediate Previous Financial Year
Top 2000 listed entities
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
NOTLISTED
Name Of Signatory
MOHANACHANDRAN A
Name Of Signatory Affirmations
MOHANACHANDRAN A
Name Of Signatory For Annual Affirmations
MOHANACHANDRAN A
Name Of Signatory For Quartely Affirmations
MOHANACHANDRAN A
Name Of The Company
BAFNA PHARMACEUTICALS LIMITED
New Name And The Old Name Of The Listed Entity
Not Applicable
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Not Applicable
Place
CHENNAI
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Not Applicable
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Not Applicable
SCORES Registration ID
B00011
Scrip Code
532989
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Not Applicable
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Not Applicable
Symbol
BAFNAPH
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Not Applicable
Type Of Any Guarantee Or Comfort Letter Of KM Ps Or Any Other Entity Controlled By Them
Not Applicable
Type Of Any Guarantee Or Comfort Letter Of Promoter Group Or Any Other Entity Controlled By Them
Not Applicable
Type Of Any Guarantee Or Comfort Letter Of Promoter Or Any Other Entity Controlled By Them
Not Applicable
Type Of Company
Equity
Type Of Security Of KM Ps Or Any Other Entity Controlled By Them
Not Applicable
Type Of Security Of Promoter Group Or Any Other Entity Controlled By Them
Not Applicable
Type Of Security Of Promoter Or Any Other Entity Controlled By Them
Not Applicable
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Yes
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
Yes

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
No
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Date of BirthDisqualifiedStatusSpecial ResolutionInitial AppointmentRe-appointmentTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MsSHANMUGAM HEMALATHA******02714329Executive DirectorNot Applicable19-Apr-1975NoActiveNot Applicable10-Sep-202010-Sep-20231010
2MrVINAYAK DINESH DENDUKURI******07601309Executive DirectorNot Applicable03-Jan-1988NoActiveNot Applicable26-Jun-20231000
3MrsAKILA CHINTALAPATI RAJU******07590312Non-Executive - Non Independent DirectorNot Applicable10-Oct-1987NoActiveNot Applicable10-Sep-20201010
4MrUPENDAR MEKALA REDDY******08898174Non-Executive - Non Independent DirectorNot Applicable10-Dec-1981NoActiveNot Applicable26-Jun-20231010
5MrsRAVICHANDRAN CHITRA******07749125Non-Executive - Independent DirectorChairperson25-Apr-1961NoActiveNot Applicable12-Nov-202012-Nov-202564.652221
6MrPALAMADAI KRISHNAN SUNDARESAN******06954189Non-Executive - Independent DirectorNot Applicable20-May-1956NoActiveNot Applicable19-Sep-202519-Sep-20256.421100
7MrNAVIN KUMAR******08778662Non-Executive - Independent DirectorNot Applicable02-Oct-1980NoActiveNot Applicable23-Jun-202523-Jun-202529-Sep-20262233

Committee Disclosures

Entry CompComit122
Date of Appointment
25-Jun-2021
Entry CompComit123
Date of Appointment
25-Jun-2021
Entry CompComit124
Date of Appointment
02-Nov-2023
Entry CompComit14
Date of Appointment
25-Jun-2025
Entry CompComit15
Date of Appointment
12-Nov-2020
Entry CompComit16
Date of Appointment
02-Nov-2023
Entry CompComit41
Date of Appointment
25-Jun-2025
Entry CompComit42
Date of Appointment
20-May-2025
Entry CompComit43
Date of Appointment
10-Sep-2020
Entry CompComit68
Date of Appointment
12-Nov-2020
Entry CompComit69
Date of Appointment
10-Sep-2020
Entry CompComit70
Date of Appointment
07-Apr-2023
Entry MainD
Composition And Role Of Risk Management Committee
Not Applicable
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
www.bafnapharma.com
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
No
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Not Applicable
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Corporate Social Responsibility Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
08778662
Member Name
NAVIN KUMAR
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
07749125
Member Name
RAVICHANDRAN CHITRA
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
08898174
Member Name
UPENDAR MEKALA REDDY
Position
Non-Executive - Non Independent Director

Audit Committee

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Chairperson
Director DIN
07749125
Member Name
RAVICHANDRAN CHITRA
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
02714329
Member Name
SHANMUGAM HEMALATHA
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
07590312
Member Name
AKILA CHINTALAPATI RAJU
Position
Non-Executive - Non Independent Director

Corporate Social Responsibility Committee

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
08778662
Member Name
NAVIN KUMAR
Notes
Appointed as Chairperson w.e.f 13-08-2025
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
07749125
Member Name
RAVICHANDRAN CHITRA
Notes
Appointed as Member w.e.f 13-08-2025; Ceased as Chairperson w.e.f 12-08-2025.
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
07590312
Member Name
AKILA CHINTALAPATI RAJU
Position
Non-Executive - Non Independent Director

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
07749125
Member Name
RAVICHANDRAN CHITRA
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
02714329
Member Name
SHANMUGAM HEMALATHA
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
07590312
Member Name
AKILA CHINTALAPATI RAJU
Position
Non-Executive - Non Independent Director

Stakeholders Relationship Committee

Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Not Applicable
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Not Applicable
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Not Applicable
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
11-Nov-2025
Number Of Directors Present In Meeting Of Board Of Directors
6
Number Of Independent Directors Attending The Meeting
2
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingBOD2
Dates Of Meeting If Any In The Relevant Quarter
11-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
91
Number Of Directors Present In Meeting Of Board Of Directors
6
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingBOD3
Dates Of Meeting If Any In The Relevant Quarter
27-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
43
Number Of Directors Present In Meeting Of Board Of Directors
6
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
11-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Relevant Quarter
11-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
91
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Relevant Quarter
27-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
43
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Relevant Quarter
11-Feb-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Relevant Quarter
11-Feb-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
www.bafnapharma.com
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
www.bafnapharma.com
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
0
No Of Investor Complaints During The Period
0
No Of Investor Complaints Received During The Period
0
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
0
Entry PY_I
No Of Investor Complaints
0
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Not Applicable
Reason For Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Not Applicable To The Entity
No acquisition of shares or voting rights aggregating to 5% or more in an unlisted company was made during the quarter ended 31.03.2026
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
No
Entry I_OngoingTaxLitigationsOrDisputes1
Current Status
The Income Tax Department has passed an order under Section 156A of the Income Tax Act, 1961, pursuant to which the liability has become NIL after adjustment of Rs.10 lakhs paid by the Company in accordance with the approved Resolution Plan. The matter is presently pending before the Hon’ble High Court of Madras for disposal.
Date of Initiation
25-Apr-2022
Opposing Party
Deputy Commissioner of Income Tax
Status (Previous Disclosure)
The litigation pertains to the AY 2015-16. The Company has filed a writ before the Hon'ble High Court of Madras. Interim stay has been granted. Expected financial implications amount to 273.87 Lakhs.
Entry I_OngoingTaxLitigationsOrDisputes2
Current Status
The Income Tax Department has passed an order under Section 156A of the Income Tax Act, 1961, pursuant to which the liability has become NIL. The matter is presently pending before the Hon’ble High Court of Madras for disposal.
Date of Initiation
27-Sep-2022
Opposing Party
Deputy Commissioner of Income Tax
Status (Previous Disclosure)
The litigation pertains to the AY 2015-16. The Company has filed a writ before the Hon'ble High Court of Madras. Interim stay has been granted. Expected financial implications amount to 68.31 Lakhs.
Entry I_OngoingTaxLitigationsOrDisputes3
Current Status
Awaiting for Orders.
Date of Initiation
22-Mar-2022
Opposing Party
Deputy Commissioner of GST & Central Excise, Egmore Division, Chennai
Status (Previous Disclosure)
The Company has received the GST demand notice for the period from FY 2017-18 to FY 2020-21. The Company has disputed 235.47 Lakhs and filed an appeal. The Company has filed an appeal with CGST Appeals and the appeal has been heard. Expected financial implications amount to 235.47 Lakhs.
Entry I_OngoingTaxLitigationsOrDisputes4
Current Status
The Company has filed a Writ Application before the Hon'ble High Court of Madras to quash the Orders passed by the Joint Commissioner of GST as the same was passed based on the repealed Rule 96(10) of the GST Rules, 2017 and stay has been granted.
Date of Initiation
12-Mar-2026
Opposing Party
Joint Commissioner of GST & Central Excise, Chennai North Commissionerate, Chennai
Status (Previous Disclosure)
The Company has received an Order from the Joint Commissioner, Office of Principal Commissioner of GST and Central Excise for recovery of IGST refund of Rs.331 Lakhs along with applicable interest and penalty. The Company is in the process of filing an appeal before the appropriate forum.
Entry MainD
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
Yes
Reason For Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity
No Fine or Penalty was imposed during the quarter ended 31.03.2026.
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
No